DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹726 Cr | ₹139 Cr | ₹-936 Cr | ₹-70 Cr | ₹1,275 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR REDDYS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹726 Cr |
| Mar2024 | ₹139 Cr |
| Mar2023 | ₹-936 Cr |
| Mar2022 | ₹-70 Cr |
| Mar2021 | ₹1,275 Cr |
How is Net Cash Inflow / Outflow of DR REDDYS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹726 Cr | 423.58 | |
| Mar2024 | ₹139 Cr | Positive | |
| Mar2023 | ₹-936 Cr | Negative | |
| Mar2022 | ₹-70 Cr | Negative | |
| Mar2021 | ₹1,275 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹107,004.4 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
| MANKIND PHARMA | ₹84,227.3 Cr | 2% | -0.6% | -16.4% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.3% |
-1.3% |
8.6% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses